Key facts
- Notable investors include Miracleplus, Lenovo Capital and Incubator Group, Value Capital, Leaguer Financial, IMO Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for PoreSpect Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for PoreSpect Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PoreSpect Technology
Developer of bio-macromolecule detection equipment, gene sequencers, and supporting reagents and consumables. The company offers to develop accurate, fast, low-cost, and miniaturized biological macromolecule detection equipment, gene sequencers, and supporting reagents and consumables, based on solid-state nanopore single-molecule detection technology, providing solid-state nanopore sequencers for scientific research users.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2022
- Website
- porespect.com/
- Ownership
- Privately Held (backing)
PoreSpect Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PoreSpect Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PoreSpect Technology in its N-PORT filings yet. We sweep new filings monthly.